< Back to News & Events

Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2023)

Published on

AUROBAC THERAPEUTICS

The seventh edition of the Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2023) will be held in Lyon, France on November 22-23, 2023.
The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.

I4ID2023 will build on the successes of the previous editions, the first one starting in 2017, that counted with the presence of more than 1250 participants from different countries representing over 390 organizations and 220 internationally renowned speakers exchanging on immunotherapy and new therapeutic approaches to fight infectious diseases.

The I4ID2023 will include keynote lectures, pitch talks of new innovative projects, industrial talks from pharmaceutical companies and poster presentations.
Moreover, there will be several opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering, through an online B2B platform.

More information available here.

AUROBAC THERAPEUTICS

22 Nov 2023 - 23 Nov 2023

Lyon, France

Immunotherapies & Innovations for Infectious Diseases Congress [Lyon, France]

The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach.

Share

AUROBAC THERAPEUTICS is proud to be a member of the BEAM Alliance

AUROBAC ©2024 – Legal NoticePrivacy StatementPhoto Credits